BridgeMD
New treatment option for Postprandial Glucose
Official title Ultra-processed Food-reducing Intervention and Continuous Glucose Monitoring
ClinicalTrials.gov ID: NCT07175701
What this study is testing
- What it's testing
- The goal of this trial is to investigate whether reduction in ultra-processed food intake through dietary counseling and education can improve postprandial glucose responses and glycemic variability compared with a usual diet in young, healthy Korean adults aged 20-30 years. The main questions it aims to answer are: \- Does reducing ultra-processed food intake, while maintaining total energy intake and usual lifestyle behaviors, improve postprandial glucose and lower glycemic variability in healthy adults without diabetes?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 39. Healthy volunteers may be eligible.
You may be able to join if
- Korean adults aged 20-39 years
- Not currently pregnant
- No personal history of diabetes or other glucose-related conditions
- Consume ≥25% of daily energy intake from UPFs, as assessed by an online, self-administered semi-quantitative screening food frequency questionnaire...
- No restriction on wearing a CGM device
You likely can't join if
- Unable to maintain continuous follow-up during the study period (e.g., due to special plans such as traveling)
- Planning to follow a special or restrictive diet (e.g., for weight loss) during the study period
See the full eligibility criteria
- Korean adults aged 20-39 years
- Not currently pregnant
- No personal history of diabetes or other glucose-related conditions
- Consume ≥25% of daily energy intake from UPFs, as assessed by an online, self-administered semi-quantitative screening food frequency questionnaire (FFQ)
- No restriction on wearing a CGM device
- No increased risk of bleeding
- No prior adverse reaction to CGM devices
- Willingness to participate in follow-up assessments
- Unable to maintain continuous follow-up during the study period (e.g., due to special plans such as traveling)
- Planning to follow a special or restrictive diet (e.g., for weight loss) during the study period
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 39 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.